TriSalus Life Sciences (TLSI) EBT Margin Growth (3y) (2025 - 2026)

TriSalus Life Sciences (TLSI) EBT Margin Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.82 Bn 176.53 Bn 6.27 Bn -305.00
2 Stryker 129.01 Bn 126.13 Bn 3.81 Bn -9.00
3 Medtronic 108.52 Bn 99.30 Bn 6.41 Bn 55.00
4 Boston Scientific 68.59 Bn 67.14 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 48.35 Bn 44.68 Bn 1.29 Bn -480.00
6 Dexcom 28.35 Bn 27.23 Bn 750.30 Mn 1,391.00
7 GE HealthCare Technologies 28.11 Bn 25.82 Bn 1.98 Bn -176.00
8 Smith & Nephew 26.89 Bn 26.32 Bn - -
9 Koninklijke Philips 24.28 Bn 21.15 Bn 2.07 Bn 2,114.00
10 TriSalus Life Sciences 225.74 Mn 169.19 Mn 7.67 Mn 29,458.00

Historic Data

Download Data
DateValue
Mar 31, 2026 29,458.00
Dec 31, 2025 62,472.00
Sep 30, 2025 11,287.00